Enzo Biochem Inc
ENZ
Company Profile
Business description
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment.
Contact
527 Madison Avenue
New York NY 10022
USAT: +1 212 583-0100
E: peckert@enzo.com
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 July 2024
Employees
190
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
---|---|---|---|
All Ordinaries | 8,138.90 | 118.00 | 1.47% |
CAC 40 | 8,239.99 | 14.20 | 0.17% |
DAX 40 | 18,869.36 | 152.94 | 0.82% |
Dow JONES (US) | 39,908.00 | 349.89 | 0.88% |
FTSE 100 | 8,445.80 | 17.67 | 0.21% |
HKSE | 19,376.79 | 303.08 | 1.59% |
NASDAQ | 16,742.39 | 231.21 | 1.40% |
Nikkei 225 | 38,697.22 | 311.49 | 0.81% |
NZX 50 Index | 11,699.27 | 173.39 | 1.50% |
S&P 500 | 5,308.15 | 61.47 | 1.17% |
S&P/ASX 200 | 7,871.20 | 117.50 | 1.52% |
SSE Composite Index | 3,134.97 | 15.07 | 0.48% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
---|---|---|---|
Sayona Mining Ltd SYA | 0.05 | 0.00 | 2.13% |
PYC Therapeutics Ltd PYC | 0.10 | 0.01 | -4.76% |
Telstra Group Ltd TLS | 3.70 | 0.03 | 0.82% |
Pantoro Ltd PNR | 0.09 | 0.01 | 9.26% |
South32 Ltd S32 | 3.73 | 0.06 | 1.50% |
Pilbara Minerals Ltd PLS | 4.00 | 0.02 | 0.50% |
Red 5 Ltd RED | 0.49 | 0.02 | 4.26% |
De Grey Mining Ltd DEG | 1.19 | 0.05 | 4.39% |
Renascor Resources Ltd RNU | 0.12 | 0.02 | -11.54% |
Imugene Ltd IMU | 0.07 | 0.00 | 1.43% |